Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.
N K Cheung(Memorial Sloan Kettering Cancer Center), Steven M. Larson(Memorial Sloan Kettering Cancer Center), Glenn Heller(Memorial Sloan Kettering Cancer Center), Brian H. Kushner(Memorial Sloan Kettering Cancer Center), Irene Y. Cheung, Mary Ann Bonilla(St. Joseph's Hospital and Medical Center), S J Yeh, Adela Cañete(Universitat de València)
PubMed
April 15, 1994
Cited by 81
Related Papers
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
|The Lancet|2010|1.1k
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
|New England Journal of Medicine|2013|825
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia
|Blood|2000|560
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
|Journal of Clinical Oncology|1987|417
Imaging Transgene Expression with Radionuclide Imaging Technologies
|Neoplasia|2000|362